DOTA-TOC

DOTA-Tyr3-octreotate

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DOTA-TOC, covering 2015-08-07 to 2015-08-07. Get the full timeline:

Most recent: Clinical Trial Update: DOTA-TOC in Metastasized Neuroendocrine Tumors [Phase 2]